Taiwan Advanced Nanotech Inc. (TPEX:6797)

Market Cap	451.76M -24.8%
Revenue (ttm)	172.11M -13.8%
Net Income	-202.56M
EPS	-6.59
Shares Out	30.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	139,675
Average Volume	82,070
Open	15.30
Previous Close	15.30
Day's Range	13.80 - 15.30
52-Week Range	13.50 - 23.50
Beta	0.53
RSI	39.36
Earnings Date	Mar 17, 2026

About Taiwan Advanced Nanotech

Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plates; filling line systems; and molecular biology reagents. It also provides OEM/ODM services. The company was founded in 2004 and is based in Taoyuan Ci...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6797

Financial Performance

In 2024, Taiwan Advanced Nanotech's revenue was 197.59 million, a decrease of -19.55% compared to the previous year's 245.61 million. Losses were -190.57 million, -8.46% less than in 2023.